Trial · NCT01168973
Adverse events670
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 670
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Ramucirumab and Docetaxel | 135 | 627 | 306 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo and Docetaxel | 174 | 618 | 399 |
| other | Leukopenia | Blood and lymphatic system disorders | Ramucirumab and Docetaxel | 79 | 627 | 259 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo and Docetaxel | 68 | 618 | 151 |
| other | Neutropenia | Blood and lymphatic system disorders | Ramucirumab and Docetaxel | 228 | 627 | 547 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo and Docetaxel | 188 | 618 | 415 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Ramucirumab and Docetaxel | 51 | 627 | 114 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo and Docetaxel | 27 | 618 | 48 |
| other | Lacrimation increased | Eye disorders | Ramucirumab and Docetaxel | 85 | 627 | 100 |
| other | Lacrimation increased | Eye disorders | Placebo and Docetaxel | 29 | 618 | 31 |
| other | Abdominal pain | Gastrointestinal disorders | Ramucirumab and Docetaxel | 56 | 627 | 69 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo and Docetaxel | 35 | 618 | 41 |
| other | Constipation | Gastrointestinal disorders | Ramucirumab and Docetaxel | 107 | 627 | 135 |
| other | Constipation | Gastrointestinal disorders | Placebo and Docetaxel | 110 | 618 | 132 |
| other | Diarrhoea | Gastrointestinal disorders | Ramucirumab and Docetaxel | 200 | 627 | 338 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo and Docetaxel | 175 | 618 | 226 |
| other | Dyspepsia | Gastrointestinal disorders | Ramucirumab and Docetaxel | 37 | 627 | 47 |
| other | Dyspepsia | Gastrointestinal disorders | Placebo and Docetaxel | 18 | 618 | 25 |
| other | Nausea | Gastrointestinal disorders | Ramucirumab and Docetaxel | 170 | 627 | 236 |
| other | Nausea | Gastrointestinal disorders | Placebo and Docetaxel | 173 | 618 | 256 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01168973/events